cGMP: Strategies for implementation and compliance for Phase I Investigational Drug and Biologic products 2011
24 Jan 2011
Webinar
Description
Topics
Historical FDA cGMP requirements for drugs and biologics
Key aspects of FDA cGMP requirements for IND products
Regulatory guidelines; FDA, ICH, CHMP, EMEA
Practical implications
Who should Attend
R&D investigators
Executive management
Pre-clinical and clinical
Product development
QA/ QC
Regulatory affairs
Consultants
Marketing
Training
Past Events
cGMP: Strategies for implementation and compliance for Phase I Investigational Drug and Biologic products 2011 - 24 Jan 2011, Webinar (14190)
Important
Please, check "cGMP: Strategies for implementation and compliance for Phase I Investigational Drug and Biologic products" official website for possible changes, before making any traveling arrangements
